🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of additio...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02576327
Treatments Being Tested
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
This REMAP Periop ERP domain study falls under the Periop Core Protocol, wh...
Status
Completed
Location
UPMC Magee-Womens Hospital
Start Date
2023-05-15
Trial ID
NCT04606264
This is a single-center, open, randomized, single-dose, two-cycle, two-sequ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-01-23
Trial ID
NCT06226506
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of a 3...
Status
Completed
Location
Phoenix Childrens Hospital ( Site 1101)
Start Date
2019-09-09
Trial ID
NCT04054193
Treatments Being Tested
As a preventive for postoperative nausea and vomiting in patients undergoin...
Status
Enrolling By Invitation
Location
Samsung Medical Center
Start Date
2023-08-18
Trial ID
NCT05773950
Treatments Being Tested
Chemotherapy induced nausea and vomiting (CINV) is one of the few mostly ob...
Status
Completed
Location
Dr. BRA IRCH, AIIMS
Start Date
2011-08
Trial ID
NCT01402024
Treatments Being Tested
Compared With Fosaprepitant dimeglumine for Injection and Palonosetron Hydr...
Status
Completed
Location
Zhe jiangCancer Hospital
Start Date
2025-01-03
Trial ID
NCT07081256
To determine the best method to prevent CINV caused by TC regimen in patien...
Status
Completed
Location
Dengfeng Wang
Start Date
2024-05-31
Trial ID
NCT06007586
Treatments Being Tested
This study is aimed to evaluate the efficacy and safety of Fosrolapitant an...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT07692451
Treatments Being Tested